Lupin’s arm recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate in US market

15 Feb 2021 Evaluate

Lupin’s wholly-owned subsidiary -- Lupin Pharmaceuticals Inc, is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension in the American market. The company has initiated the recall of the affected lot due to ‘Failed Impurities/Degradation Specifications’. The product has been manufactured at Lupin's Aurangabad (Maharashtra) based manufacturing plant. The company initiated the recall, which the US health regulator has classified as Class III, on January 21 this year. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×